Basic Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2005; 11(44): 6948-6953
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.6948
Table 4 Baseline characteristics of patients treated for 2 years1
Total (range)SR-ALTNR-ALTSR-DNNR-DNA
n14775728562
Male/female112/3552/23Dec-6062/23Dec-50
ALT (U/L)221.6±493.5 (17-4491)258.9±548.5182.3±428.2291.3±626.3122.2±132.0
Albumin (g/dL)3.8±0.6 (2.2-4.9)3.8±0.53.8±0.63.8±0.53.9±0.6
Bilirubin (mg/dL)1.5±2.1 (0.3-12.9)1.7±2.51.3±1.71.7±2.61.0±1.1
Platelet (104/mL)13.8±6.2 (3.4-33.6)12.9±5.414.6±6.813.1±5.514.9±5.6
BSA (m2)1.71±0.18 (1.30-2.17)1.67±0.181.76±0.171.70±0.181.73±0.18
HBV-DNA
≤5 (LEG/mL)18117126
5< ≤620713119
6< ≤74223192616
7<6935343831
HBeAg +/–82/6541/3441/3141/4541/20
Age (yr)48.9±11.4 (19-73)
CH/LC [Child A/B/C]95/54 [43/3/8]